Merck acquires SpringWorks Therapeutics in multibillion dollar deal Mergers & Acquisitions April 28, 2025 Merck has reportedly moved to strengthen its position in oncology and rare diseases with a $3.9 billion agreement to acquire SpringWorks Therapeutics